STRIVE-ON Data Readout Expected First Calendar Quarter 2025; NDA Submission on Track for 1H Calendar 2025 ... and Results of Operations" sections of the Company's Annual Report on Form 10-K for the ...
(RTTNews) - Biotechnology company Unicycive Therapeutics, Inc. (UNCY) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Oxylanthanum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback